华兰股份：10月21日召开董事会会议

Core Viewpoint - Hualan Co., Ltd. announced the convening of its sixth board meeting to review the third quarter report for 2025, indicating ongoing corporate governance and financial oversight [1] Company Summary - Hualan Co., Ltd. reported that for the first half of 2025, 99.07% of its revenue came from the pharmaceutical manufacturing sector, while other businesses contributed only 0.93% [1] - As of the report, Hualan Co., Ltd. has a market capitalization of 6.5 billion yuan [1]